West Pharmaceutical Services | WST - Stammkapital

Aktienkurs
306.16
Täglich Wechseln
-3.54 -1.14%
Monatlich
23.94%
Jährlich
42.70%
Q2 Prognose
299.61




Stammkapital Veränderung Datum
Align Technology USD 71.75M 736K 2025-12
Avanos Medical USD 46.46M 39.46K 2025-12
Baxter International USD 514.28M 168.72M 2025-12
Becton, Dickinson and Co. USD 284.91M 1.72M 2025-12
Charles River Laboratories USD 49.22M 2K 2025-12
Cooper Companies USD 195.1M 3.71M 2025-12
Dentsply International USD 199.5M 196.5M 2025-09
Haemonetics USD 46.83M 82K 2025-12
ICU Medical USD 24.69M 2K 2025-12
Insulet USD 70.35M 1000 2025-12
Integra LifeSciences USD 77.89M 34K 2025-12
IQVIA Holdings USD 169.6M 700K 2025-12
J&J USD 2.41B 1.74M 2025-12
Medtronic USD 1.28B 1.38M 2025-12
Merit Medical Systems USD 59.29M 72K 2025-09
Neogen USD 217.67M 147K 2025-12
OraSure Technologies USD 70.39M 1.87M 2025-12
Quidel USD 67.9M 200K 2025-09
Repligen USD 56.32M 42K 2025-12
Solventum Corp USD 173.49M 51.34K 2025-12
STAAR Surgical USD 49.4M 49K 2025-12
Terumo JPY 1.48B 0 2025-12
Utah Medical Products USD 3.19M 3.15M 2025-12
West Pharmaceutical Services USD 70.9M 1.1M 2026-03